Yu Zong Chen Selected Research

Yu Zong Chen Research Topics

9	Neoplasms (Cancer) 01/2022 - 03/2006
2	COVID-19 01/2022 - 01/2020
2	Drug-Related Side Effects and Adverse Reactions 07/2006 - 01/2003
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Nervous System Neoplasms (Neoplasms, Nervous System) 12/2022
1	Virus Diseases (Viral Diseases) 12/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2019
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Drug-Induced Dyskinesia (Dyskinesia, Drug Induced) 01/2018
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018

5	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2003
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2021 - 02/2013
1	Drug CombinationsIBA 01/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 10/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2018
1	Hydroxamic Acids (Hydroxamic Acid)IBA 01/2017
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2015
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2010
1	ErbB Receptors (EGF Receptor)IBA 09/2009
1	Protein Kinases (Protein Kinase)IBA 09/2009
1	Oncogene Proteins (Oncogene Protein)IBA 09/2009
1	PolyphenolsIBA 03/2006
1	Tannic Acid FDA Link 03/2006

5	Therapeutics 01/2021 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2010